Drug Resistance Reversal Potential of Ursolic Acid Derivatives against Nalidixic Acid- and Multidrug-resistantEscherichia coli

QSAR and docking studies on chalcone derivatives for antitubercular activity againstM. tuberculosisH37Rv

(2014) Dharmendra Kumar Yadav et al.   JOURNAL OF CHEMOMETRICS

In vivo efficacy and synergistic interaction of 16α-hydroxycleroda-3, 13 (14) Z-dien-15, 16-olide, a clerodane diterpene from Polyalthia longifolia against methicillin-resistant Staphylococcus aureus

(2013) Vivek Kumar Gupta et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Antibacterial and Synergy of Clavine Alkaloid Lysergol and its Derivatives Against Nalidixic Acid-ResistantEscherichia coli

(2013) Anupam Maurya et al.   Chemical Biology & Drug Design

4-Hydroxy-α-Tetralone and its Derivative as Drug Resistance Reversal Agents in Multi Drug ResistantEscherichia coli

(2013) Gaurav R. Dwivedi et al.   Chemical Biology & Drug Design

QSAR, docking and ADMET studies of camptothecin derivatives as inhibitors of DNA topoisomerase-I

(2013) Dharmendra K. Yadav et al.   JOURNAL OF CHEMOMETRICS

Cytotoxic Activity of Ursolic Acid Derivatives Obtained by Isolation and Oxidative Derivatization

(2013) Kishor Mazumder et al.   MOLECULES

The Future of Antibiotics and Resistance

(2013) Brad Spellberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus

(2012) N. P. Kalia et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Enhancement by novel anti-methicillin-resistant Staphylococcus aureus compound HT61 of the activity of neomycin, gentamicin, mupirocin and chlorhexidine: in vitro and in vivo studies

(2012) Y. Hu et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antimicrobial Resistance and Spread of Multi Drug Resistant Escherichia coli Isolates Collected from Nine Urology Services in the Euregion Meuse-Rhine

(2012) Christina F. M. van der Donk et al.   PLoS One

Ursolic acid causes DNA-damage, P53-mediated, mitochondria- and caspase-dependent human endothelial cell apoptosis, and accelerates atherosclerotic plaque formation in vivo

(2011) Barbara Messner et al.   ATHEROSCLEROSIS

Bioenhancing and Antimycobacterial Agents fromAmmannia multiflora

(2011) Harish Upadhyay et al.   PLANTA MEDICA

Botanical Drugs, Synergy, and Network Pharmacology: Forth and Back to Intelligent Mixtures

(2011) Jürg Gertsch   PLANTA MEDICA

The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020

(2010)   CLINICAL INFECTIOUS DISEASES

Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections

(2010) Julian G. Hurdle et al.   NATURE REVIEWS MICROBIOLOGY

Hospital-Acquired Infections Due to Gram-Negative Bacteria

(2010) Anton Y. Peleg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Multidrug Resistance in Bacteria

(2009) Hiroshi Nikaido   Annual Review of Biochemistry

The changing epidemiology of resistance

(2009) P. M. Hawkey et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Has the era of untreatable infections arrived?

(2009) D. M. Livermore   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Mechanisms of drug combinations: interaction and network perspectives

(2009) Jia Jia et al.   NATURE REVIEWS DRUG DISCOVERY

The Efflux Pump Inhibitor Reserpine Selects Multidrug-Resistant Streptococcus pneumoniae Strains That Overexpress the ABC Transporters PatA and PatB

(2008) M. I. Garvey et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mechanisms of drug efflux and strategies to combat them: Challenging the efflux pump of Gram-negative bacteria

(2008) Jean-Marie Pagès et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

New Methods for the Identification of Efflux Mediated MDR Bacteria, Genetic Assessment of Regulators and Efflux Pump Constituents, Characterization of Efflux Systems and Screening for Inhibitors of Efflux Pumps

(2008) M. Viveiros et al.   CURRENT DRUG TARGETS

Utilization of membrane vesicle preparations to study drug–ABC transporter interactions

(2008) Hristos Glavinas et al.   Expert Opinion on Drug Metabolism & Toxicology